DR Horton (Brazil) Performance
| D1HI34 Stock | BRL 1,012 58.84 6.17% |
The firm owns a Beta (Systematic Risk) of -0.21, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning DR Horton are expected to decrease at a much lower rate. During the bear market, DR Horton is likely to outperform the market. At this point, DR Horton has a negative expected return of -0.055%. Please make sure to confirm DR Horton's semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to decide if DR Horton performance from the past will be repeated sooner or later.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days DR Horton has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical indicators, DR Horton is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 3.2 B | |
| Total Cashflows From Investing Activities | -414.9 M |
D1HI34 |
DR Horton Relative Risk vs. Return Landscape
If you would invest 105,800 in DR Horton on August 30, 2024 and sell it today you would lose (4,600) from holding DR Horton or give up 4.35% of portfolio value over 90 days. DR Horton is generating negative expected returns and assumes 1.8851% volatility on return distribution over the 90 days horizon. Simply put, 16% of stocks are less volatile than D1HI34, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
DR Horton Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for DR Horton's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as DR Horton, and traders can use it to determine the average amount a DR Horton's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0292
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | D1HI34 |
Estimated Market Risk
| 1.89 actual daily | 16 84% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average DR Horton is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DR Horton by adding DR Horton to a well-diversified portfolio.
DR Horton Fundamentals Growth
D1HI34 Stock prices reflect investors' perceptions of the future prospects and financial health of DR Horton, and DR Horton fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on D1HI34 Stock performance.
| Return On Equity | 0.31 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 179.36 B | |||
| Shares Outstanding | 343.39 M | |||
| Price To Earning | 10.55 X | |||
| Price To Book | 1.50 X | |||
| Price To Sales | 4.76 X | |||
| Revenue | 33.48 B | |||
| EBITDA | 7.65 B | |||
| Cash And Equivalents | 2.11 B | |||
| Cash Per Share | 5.86 X | |||
| Total Debt | 6.07 B | |||
| Debt To Equity | 0.34 % | |||
| Book Value Per Share | 58.71 X | |||
| Cash Flow From Operations | 561.8 M | |||
| Earnings Per Share | 83.76 X | |||
| Total Asset | 30.35 B | |||
About DR Horton Performance
By analyzing DR Horton's fundamental ratios, stakeholders can gain valuable insights into DR Horton's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if DR Horton has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if DR Horton has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Horton, Inc. operates as a homebuilding company in East, Midwest, Southeast, South Central, Southwest, and West regions in the United States. Horton, Inc. was founded in 1978 and is based in Arlington, Texas. DR HORTON operates under Residential Construction classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 9716 people.Things to note about DR Horton performance evaluation
Checking the ongoing alerts about DR Horton for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for DR Horton help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| DR Horton generated a negative expected return over the last 90 days |
- Analyzing DR Horton's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DR Horton's stock is overvalued or undervalued compared to its peers.
- Examining DR Horton's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DR Horton's management team can have a significant impact on its success or failure. Reviewing the track record and experience of DR Horton's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of DR Horton's stock. These opinions can provide insight into DR Horton's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for D1HI34 Stock analysis
When running DR Horton's price analysis, check to measure DR Horton's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DR Horton is operating at the current time. Most of DR Horton's value examination focuses on studying past and present price action to predict the probability of DR Horton's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DR Horton's price. Additionally, you may evaluate how the addition of DR Horton to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |